Search

everythinglearnresearchcommunity

for

Search:↓

Posaconazole is a promising new treatment for toenail fungus.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Entospletinib effectively prevents eye and skin GVHD in mice.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Ruxolitinib cream may help treat severe hair loss in children.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

A group has developed therapies that show promise for treating cancer and various other conditions.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Ruxolitinib helped a man regrow his beard after years of hair loss.

Sonidegib and vismodegib have different side effects and reporting patterns.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Erlotinib can cause hair loss and scalp issues, which improve after stopping the drug.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.